CF
SMTI icon

Corebridge Financial’s Sanara MedTech SMTI Stock Holding History

Corebridge Financial’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,985
Closed -$61.3K – 2379
2025
Q1 		$61.3K Sell
1,985
-30
-1% -$1.02K ﹤0.01% 2659
2024
Q4 		$66.9K Sell
2,015
-121
-6% -$4.1K ﹤0.01% 2738
2024
Q3 		$64.6K Sell
2,136
-14
-0.7% -$437 ﹤0.01% 2791
2024
Q2 		$60.7K Buy
+2,150
New +$67.5K ﹤0.01% 2840

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Corebridge Financial's SMTI Position: Q2 2025 in Review

Corebridge Financial sold out of Sanara MedTech (SMTI) in Q2 2025, closing a stake of 1,985 shares — an estimated $61.3K sold.

Corebridge Financial first reported a position in SMTI in Q2 2024 and held it in 4 quarters. The position peaked at $66.9K in Q4 2024. 52 funds tracked by Wall St. Rank hold SMTI as of Q2 2025.

  • Corebridge Financial reported no remaining Sanara MedTech position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 1,985 Sanara MedTech shares in Q2 2025, an estimated $61.3K.
  • Corebridge Financial first reported a position in Sanara MedTech in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Sanara MedTech position peaked at $66.9K in Q4 2024.
  • 52 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.